Perspective on assessing comparability of biotechnology products--a view from Japan
Hayakawa, T.
Developments in Biologicals 109: 27-40
2002
ISSN/ISBN: 1424-6074 PMID: 12434910 Document Number: 544633
Document emailed within 1 workday
Related Documents
Hill, D.E. 1989: Regulating biotechnology licensed products Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 43(3): 139-141Röthig, H.J. 1994: Clinical trials of gene/biotechnology products Methods and Findings in Experimental and Clinical Pharmacology 16(7): 539-544
Cordoba-Rodriguez, R. 2010: Raw materials in the manufacture of biotechnology products: regulatory considerations PDA Journal of Pharmaceutical Science and Technology 64(5): 445-450
Payne, B.J. 1987: The use of hematologic parameters in applying the principles of toxicity testing to biotechnology products Progress in Clinical and Biological Research 235: 107-120
Gruber, I.M. 1988: Microbiological aspects of the biotechnology for obtaining targetted microbial synthesis products as exemplified by restrictases Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 9: 99-104
Aksiuk, I.N. 1986: Biomedical criteria for evaluating the quality of food products obtained by using new feedstuffs with the application of biotechnology Vestnik Akademii Meditsinskikh Nauk SSSR 11: 70-74
Hakim, Z.; Kucukarslan, S. 1993: Regulation of biotechnology products in the global pharmaceutical market: the case of the European community and the United States Clinical Therapeutics 15(2): 442-458; Discussion 432
Butel, J. 2011: What changes in perspective in view? Krankenpflege. Soins Infirmiers 104(6): 44-47
Sato, S. 1990: Mutagens and carcinogens in the diet. Regulatory perspective: Japan Progress in Clinical and Biological Research 347: 295-306
Zlatarev, G.; Mechkarski, S. 1979: Measurement of the Na2 35S04 in donor cornea with a view to assessing its biological properties Eksperimentalna Meditsina i Morfologiia 18(2): 112-115
Matsushita, K. 2017: Current Condition and Issues of Clinical Biobanks in Japan -From the Point of View of Laboratory Medicine- Rinsho Byori. Japanese Journal of Clinical Pathology 65(2): 181-189
Ahiko, T. 1995: The examination of tuberculosis contacts: the current situations and perspective in Japan Kekkaku: 70(1): 67-72
Merriam, J. 1999: Managing an imaging department with a business perspective. A view from the other side Radiology Management 21(2): 54-57
Mizuno, H.; Kuroda, T. 1981: Focal points in modern medicine. 5. The life of the aged in Japan--the aging society in view of population dynamics Nursing Technique 27(2): 257-269
Iwasaki, T. 1982: Historical perspective on problems of the therapy, diagnosis and prevention of tuberculosis in Japan since 1886. (2) Kekkaku: 57(7): 399-407
Hoffman, S.J.; Røttingen, J-Arne. 2012: Assessing implementation mechanisms for an international agreement on research and development for health products Bulletin of the World Health Organization 90(11): 854-863
Bartlett, L.H.; Urankar, Y.; Rinehart, G. 2012: A view of the profession: from student to dentist to seasoned veteran--a 25-year perspective Texas Dental Journal 129(11): 1181-1187
Suzuki, K.; Ishizaki, M.; Hotta, O.; Horigome, I.; Sudo, K.; Kurosawa, K.; Taguma, Y. 1994: Usefulness of dialysate fibrin degradation products and lactic dehydrogenase isoenzyme patterns in assessing the clinical course of peritonitis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 14(3): 231-235
Mbakogu, Ifeyinwa-Annastasia 2004: An over view of the problems of acquired immune deficiency syndrome (AIDS): A Nigerian social worker's perspective Journal of Human Ecology 15(3): 169-173
Nakamura, A.; Kojima, S.; Kaniwa, M. 1981: Determination of methanol in aerosol products by the modified "standard method of analysis for hygienic chemists authorized by the Pharmaceutical Society of Japan" Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 99: 121-123